VP VANISHPOINT Trademark

Trademark Overview


On Thursday, June 13, 2024, a trademark application was filed for VP VANISHPOINT with the United States Patent and Trademark Office. The USPTO has given the VP VANISHPOINT trademark a serial number of 98599265. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Sunday, March 1, 2026. This trademark is owned by Retractable Technologies, Inc.. The VP VANISHPOINT trademark is filed in the Medical Instrument Products category with the following description:

Medical instruments and apparatus, namely, syringes, injection devices for pharmaceuticals and other infusion therapies, injection instruments with needles, injection needles, catheters, infusion sets, blood tubing sets for medical purposes, blood drawing apparatus, devices for blood collection, namely, blood collection tube holders; medical instruments and apparatus, namely, IV catheter introducers, blood collection tube holders, bodily fluid collection and sampling devices for medical diagnostic uses, needle retraction apparatus, namely, retractable needles attached to medical syringes
vp vanishpoint

General Information


Serial Number98599265
Word MarkVP VANISHPOINT
Filing DateThursday, June 13, 2024
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateSunday, March 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements


Description of MarkThe mark consists of an upside down triangle forming the stylized letters V and P preceding the word VANISHPOINT containing an upper case V and P.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical instruments and apparatus, namely, syringes, injection devices for pharmaceuticals and other infusion therapies, injection instruments with needles, injection needles, catheters, infusion sets, blood tubing sets for medical purposes, blood drawing apparatus, devices for blood collection, namely, blood collection tube holders; medical instruments and apparatus, namely, IV catheter introducers, blood collection tube holders, bodily fluid collection and sampling devices for medical diagnostic uses, needle retraction apparatus, namely, retractable needles attached to medical syringes
Pseudo MarkVANISH POINT VANISH POINT

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code010
First Use Anywhere DateMonday, September 15, 2025
First Use In Commerce DateMonday, September 15, 2025

Trademark Owner History


Party NameRetractable Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLittle Elm, TX 75068
US

Party NameRetractable Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLittle Elm, TX 75068
US

Trademark Events


Event DateEvent Description
Thursday, June 13, 2024NEW APPLICATION ENTERED
Thursday, December 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 5, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 18, 2024ASSIGNED TO EXAMINER
Friday, December 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 11, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 29, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 10, 2025SOU EXTENSION 1 FILED
Thursday, January 29, 2026SOU EXTENSION 1 GRANTED
Friday, January 30, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 26, 2026TEAS STATEMENT OF USE RECEIVED
Thursday, February 26, 2026USE AMENDMENT FILED
Sunday, March 1, 2026STATEMENT OF USE PROCESSING COMPLETE